These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 1561480)

  • 1. [A review of clinical studies on the efficacy and tolerance of intravenous ciprofloxacin].
    Memoli M
    Recenti Prog Med; 1992 Jan; 83(1):27-34. PubMed ID: 1561480
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ciprofloxacin: an update on clinical experience.
    Arcieri G; Griffith E; Gruenwaldt G; Heyd A; O'Brien B; Becker N; August R
    Am J Med; 1987 Apr; 82(4A):381-6. PubMed ID: 3555063
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oral ciprofloxacin in the treatment of elderly patients with complicated urinary tract infections due to trimethoprim/sulfamethoxazole-resistant bacteria.
    Preheim LC; Cuevas TA; Roccaforte JS; Mellencamp MA; Bittner MJ
    Am J Med; 1987 Apr; 82(4A):295-300. PubMed ID: 3555051
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy and safety of oral ciprofloxacin in the treatment of serious respiratory infections.
    Fass RJ
    Am J Med; 1987 Apr; 82(4A):202-7. PubMed ID: 3555037
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ciprofloxacin: an oral quinolone for the treatment of infections with gram-negative pathogens. Committee on Antimicrobial Agents. Canadian Infectious Disease Society.
    Louie TJ
    CMAJ; 1994 Mar; 150(5):669-76. PubMed ID: 8313286
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical efficacy of ciprofloxacin in the treatment of patients with respiratory tract infections in Japan.
    Kobayashi H
    Am J Med; 1987 Apr; 82(4A):169-73. PubMed ID: 3555031
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of intravenous ciprofloxacin in patients with nosocomial lower respiratory tract infections. Impact of plasma concentrations, organism, minimum inhibitory concentration, and clinical condition on bacterial eradication.
    Peloquin CA; Cumbo TJ; Nix DE; Sands MF; Schentag JJ
    Arch Intern Med; 1989 Oct; 149(10):2269-73. PubMed ID: 2508586
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy and safety of oral ciprofloxacin in the treatment of respiratory tract infections associated with chronic hepatitis.
    Esposito S; Galante D; Bianchi W; Gagliardi R
    Am J Med; 1987 Apr; 82(4A):211-4. PubMed ID: 3555038
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ciprofloxacin in the treatment of urinary and respiratory tract infections in patients with chronic liver disease.
    Galante D; Esposito S; Barba D; Giusti G
    Chemioterapia; 1986 Oct; 5(5):322-6. PubMed ID: 3791479
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tolerance and pharmacokinetics of ciprofloxacin in the chick. Preliminary experience in subjects of pediatric age with urinary tract infections (UTI).
    Naccari F; Salpietro DC; De Sarro A; Masaracchio A; Barberi I
    Res Commun Mol Pathol Pharmacol; 1998 Feb; 99(2):187-92. PubMed ID: 9583092
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The efficacy and tolerance of Bay-o-9867 (ciprofloxacin) in the treatment of infections of the urinary tract and of the lower respiratory tract].
    Quartieri F; Bolognesi S; Sconosciuto F
    Recenti Prog Med; 1994 Feb; 85(2):96-100. PubMed ID: 8184195
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oral ciprofloxacin in resistant urinary tract infections.
    Ryan JL; Berenson CS; Greco TP; Mangi RJ; Sims M; Thornton GF; Andriole VT
    Am J Med; 1987 Apr; 82(4A):303-6. PubMed ID: 3555052
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oral ciprofloxacin versus intravenous therapy with other non-quinolone agents: a study of 291 infections.
    Lorian V; Pavletich K
    Drugs Exp Clin Res; 1994; 20(5):209-14. PubMed ID: 7875058
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of intravenous ciprofloxacin in difficult-to-treat infections.
    Giamarellou H; Galanakis N
    Am J Med; 1987 Apr; 82(4A):346-51. PubMed ID: 3555059
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sequential intravenous/oral ciprofloxacin as an empiric antimicrobial therapy: results of a Canadian multicenter study. The Canadian Collaborative Investigational Group.
    Davis C
    Clin Ther; 1994; 16(3):505-21. PubMed ID: 7923317
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oral ciprofloxacin therapy for gram-negative bacillary osteomyelitis.
    Lesse AJ; Freer C; Salata RA; Francis JB; Scheld WM
    Am J Med; 1987 Apr; 82(4A):247-53. PubMed ID: 3555043
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Once-daily fleroxacin versus twice-daily ciprofloxacin in the treatment of complicated urinary tract infections.
    Frankenschmidt A; Naber KG; Bischoff W; Kullmann K
    J Urol; 1997 Oct; 158(4):1494-9. PubMed ID: 9302150
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical efficacy of ciprofloxacin therapy for gram-negative bacillary osteomyelitis.
    Hessen MT; Ingerman MJ; Kaufman DH; Weiner P; Santoro J; Korzeniowski OM; Boscia J; Topiel M; Bush LM; Kaye D
    Am J Med; 1987 Apr; 82(4A):262-5. PubMed ID: 3555045
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Controlled, comparative study of ciprofloxacin versus ampicillin in treatment of bacterial respiratory tract infections.
    Wollschlager CM; Raoof S; Khan FA; Guarneri JJ; LaBombardi V; Afzal Q
    Am J Med; 1987 Apr; 82(4A):164-8. PubMed ID: 3555030
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ciprofloxacin.
    Terp DK; Rybak MJ
    Drug Intell Clin Pharm; 1987; 21(7-8):568-74. PubMed ID: 3301247
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.